{"nct_id":"NCT06464692","title":"Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer","status":"RECRUITING","status_verified_date":"2025-05","start_date":"2024-09-30","start_date_type":"ACTUAL","primary_completion_date":"2028-09","primary_completion_date_type":"ESTIMATED","completion_date":"2028-09","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["ABBV"]}